GlaxoSmithKline Pakistan Limited announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was PKR 9,058.094 million compared to PKR 7,738.393 million a year ago. Operating income was PKR 1,459.721 million compared to PKR 1,235.381 million a year ago. Net income was PKR 977.497 million compared to PKR 817.784 million a year ago. Basic earnings per share from continuing operations was PKR 3.07 compared to PKR 2.57 a year ago. For the half year, sales was PKR 16,751.603 million compared to PKR 15,772.309 million a year ago. Operating income was PKR 2,591.769 million compared to PKR 1,928.938 million a year ago. Net income was PKR 1,703.044 million compared to PKR 1,243.348 million a year ago. Basic earnings per share from continuing operations was PKR 5.35 compared to PKR 3.9 a year ago.